Announcement, Partner Highlight, Press Release | 08.24.22 LumaBridge and the Parker Institute for Cancer Immunotherapy Form Strategic Alliance to Speed Access to Clinical Trial Services for Partners
Announcement, Our Impact, Press Release | 07.27.22 Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers
Announcement, Partner Highlight, Press Release | 06.08.22 The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
Announcement, Press Release | 06.03.22 Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer
Announcement, Press Release | 11.03.21 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Dosed in First-Line Pancreatic Cancer Platform Trial
Partner Highlight | 09.30.21 Connecting Pancreatic Cancer Patients with Innovative Immunotherapies: PICI and 1440 Foundation
Our Impact, Partner Highlight | 06.24.21 All the Right Ingredients: A Q&A with the Founders of ArsenalBio
Partner Highlight, Press Release | 06.15.21 NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer
Announcement, Our Impact, Research Update | 05.19.21 PICI Makes Progress in Toughest Tumor Types with Pancreatic Cancer Combo, Immune Activity in Cold Tumors
Partner Highlight | 05.13.21 Empowering Pancreatic Cancer Patients and Delivering Innovative Immunotherapies: 1440 Foundation